Compare Current Ratio Across Equities

You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.
Specify up to 10 symbols:
Apply

Cross Equities Current Ratio Analysis

Compare Fate Therapeutics, Sana Biotechnology, and Caribou Biosciences Current Ratio Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
FATE1.81991.81992.019211.880710.88674.88456.14499.28557.52658.16695.77727.79264.40228.48065.48
SANA18.261118.261118.261118.261118.261118.261118.261118.261118.26117.275412.22435.6243.98583.3113.15
CRBU5.65675.65675.65675.65675.65675.65675.65675.65675.65675.65671.961915.14559.252311.97237.04
RCUS17.975317.975317.975317.975317.975317.975317.975313.898215.29078.4876.04174.10215.52854.51634.29
HRTX23.57144.939113.021210.42985.41356.8281.60442.21054.86044.95393.06523.58052.49452.3692.25
ALLO15.885915.885915.885915.885915.885915.885915.885915.885915.885916.46298.960216.80339.712.382114.71
BTAI0.0060.0060.0060.0060.0060.0060.0060.38089.26424.027818.330113.97786.16662.64582.51
KPTI3.24333.24330.494354.317716.88911.73677.98963.00047.1345.90439753.50124.95773.36683.2
XFOR1.25611.25611.25611.25611.25611.25610.47410.52386.498713.68466.97256.26675.76415.33975.05
HOOK17.337817.337817.337817.337817.337817.337817.337817.33784.24038.67628.11163.69334.1313.50383.33

Fate Therapeutics, Sana Biotechnology, and Caribou Biosciences Current Ratio description

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Go
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Go
Power Assets Idea
Power Assets
Invested over 200 shares
Go
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Go
Business Services Idea
Business Services
Invested few shares
Go
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Go
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Go
Impulse Idea
Impulse
Invested few shares
Go
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Go
Investing Idea
Investing
Invested few shares
Go
Electronic Equipment Idea
Electronic Equipment
Invested few shares
Go
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY